Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer.

Kuninty PR, Bansal R, De Geus SWL, Mardhian DF, Schnittert J, van Baarlen J, Storm G, Bijlsma MF, van Laarhoven HW, Metselaar JM, Kuppen PJK, Vahrmeijer AL, Östman A, Sier CFM, Prakash J.

Sci Adv. 2019 Sep 4;5(9):eaax2770. doi: 10.1126/sciadv.aax2770. eCollection 2019 Sep.

PMID:
31517053
2.

Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.

Schnittert J, Bansal R, Mardhian DF, van Baarlen J, Östman A, Prakash J.

FASEB J. 2019 May;33(5):6609-6621. doi: 10.1096/fj.201802336R. Epub 2019 Feb 26.

PMID:
30808244
3.

Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis.

Nagórniewicz B, Mardhian DF, Booijink R, Storm G, Prakash J, Bansal R.

Nanomedicine. 2019 Apr;17:106-118. doi: 10.1016/j.nano.2018.12.008. Epub 2019 Jan 22.

4.

Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.

Mardhian DF, Storm G, Bansal R, Prakash J.

J Control Release. 2018 Nov 28;290:1-10. doi: 10.1016/j.jconrel.2018.09.031. Epub 2018 Oct 2.

Supplemental Content

Loading ...
Support Center